Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

449 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Familial occurrence of sequential B-cell lymphoma and myeloproliferative disease.
Au WY, Leung R, Mok T, Fung A, Liang R. Au WY, et al. Among authors: mok t. Ann Hematol. 2008 Nov;87(11):931-2. doi: 10.1007/s00277-008-0503-y. Epub 2008 Jun 3. Ann Hematol. 2008. PMID: 18521603 No abstract available.
Unusual abdominal tumors: case 4. Multiple lymphomatous polyposis in mantle cell lymphoma.
Lam KC, Yeo W, Lee JF, Chow J, Mok TS. Lam KC, et al. J Clin Oncol. 2003 Mar 1;21(5):955-6. doi: 10.1200/JCO.2003.11.124. J Clin Oncol. 2003. PMID: 12610203 No abstract available.
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.
Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B. Yeo W, et al. Among authors: mok ts. Ann Oncol. 2006 Jul;17(7):1083-9. doi: 10.1093/annonc/mdl065. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600982
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.
Yeo W, Lam KC, Zee B, Chan PS, Mo FK, Ho WM, Wong WL, Leung TW, Chan AT, Ma B, Mok TS, Johnson PJ. Yeo W, et al. Among authors: mok ts. Ann Oncol. 2004 Nov;15(11):1661-6. doi: 10.1093/annonc/mdh430. Ann Oncol. 2004. PMID: 15520068 Clinical Trial.
A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity.
Mok TS, Yeo W, Johnson PJ, Hui P, Ho WM, Lam KC, Xu M, Chak K, Chan A, Wong H, Mo F, Zee B. Mok TS, et al. Ann Oncol. 2007 Apr;18(4):768-74. doi: 10.1093/annonc/mdl465. Epub 2007 Jan 17. Ann Oncol. 2007. PMID: 17229769 Clinical Trial.
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer).
Nokihara H, Lu S, Mok TSK, Nakagawa K, Yamamoto N, Shi YK, Zhang L, Soo RA, Yang JC, Sugawara S, Nishio M, Takahashi T, Goto K, Chang J, Maemondo M, Ichinose Y, Cheng Y, Lim WT, Morita S, Tamura T. Nokihara H, et al. Among authors: mok tsk. Ann Oncol. 2017 Nov 1;28(11):2698-2706. doi: 10.1093/annonc/mdx419. Ann Oncol. 2017. PMID: 29045553 Free PMC article. Clinical Trial.
The Role of Radiotherapy in Epidermal Growth Factor Receptor Mutation-positive Patients with Oligoprogression: A Matched-cohort Analysis.
Chan OSH, Lee VHF, Mok TSK, Mo F, Chang ATY, Yeung RMW. Chan OSH, et al. Among authors: mok tsk. Clin Oncol (R Coll Radiol). 2017 Sep;29(9):568-575. doi: 10.1016/j.clon.2017.04.035. Epub 2017 May 9. Clin Oncol (R Coll Radiol). 2017. PMID: 28499791
A phase II study of gemcitabine plus oral etoposide in the treatment of patients with advanced nonsmall cell lung carcinoma.
Mok TS, Zee B, Chan AT, Yeo W, Yang WT, Yim A, Leung SF, Nguyen B, Leung TW, Johnson P. Mok TS, et al. Cancer. 2000 Aug 1;89(3):543-50. Cancer. 2000. PMID: 10931453 Clinical Trial.
Randomized phase II study of two intercalated combinations of eribulin mesylate and erlotinib in patients with previously treated advanced non-small-cell lung cancer.
Mok TS, Geater SL, Iannotti N, Thongprasert S, Spira A, Smith D, Lee V, Lim WT, Reyderman L, Wang B, Gopalakrishna P, Garzon F, Xu L, Reynolds C. Mok TS, et al. Ann Oncol. 2014 Aug;25(8):1578-84. doi: 10.1093/annonc/mdu174. Epub 2014 May 14. Ann Oncol. 2014. PMID: 24827127 Clinical Trial.
Hepatocellular carcinoma and lymphoma--two hepatitis B virus-related malignant diseases.
Yeo W, Hui P, Chow JH, Mok TS. Yeo W, et al. Among authors: mok ts. Lancet Oncol. 2001 Sep;2(9):543. doi: 10.1016/s1470-2045(01)00487-9. Lancet Oncol. 2001. PMID: 11905708 No abstract available.
449 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback